表紙
市場調查報告書

性感染疾病診斷檢驗的全球市場:各檢驗類型,各地區的市場規模,佔有率,展望,機會分析:2020年∼2027年

Diagnostic Testing of STDs Market, By Test Type, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

出版商 Coherent Market Insights 商品編碼 948356
出版日期 內容資訊 英文 155 Pages
商品交期: 2-3個工作天內
價格
性感染疾病診斷檢驗的全球市場:各檢驗類型,各地區的市場規模,佔有率,展望,機會分析:2020年∼2027年 Diagnostic Testing of STDs Market, By Test Type, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027
出版日期: 2020年06月16日內容資訊: 英文 155 Pages
簡介

性感染疾病(STD),是透過性的接觸傳染的疾病,STD診斷檢驗用作為各種疾病的識別和診斷。市場擴大的原動力,是新的診斷檢驗的認證和上市,人們的意識高漲,開發中國家和已開發國家的STD發生率增加等要素。

本報告提供全球STD診斷檢驗市場調查,市場力學,法規,趨勢分析,各用途、各零件、各地區的分析,競爭情形等資訊。

目錄

第1章 調查的目的與前提

第2章 市場概要

  • 報告概要
    • 市場定義和範圍
  • 摘要整理
    • 檢驗的各類型
    • 各國
    • 市場機會藍圖

第3章 市場力學,法規,趨勢分析

  • 市場動態
    • 成長促進因素
    • 成長阻礙因素
    • 市場機會
  • 影響分析
  • 主要的動向
  • 產品銷售
  • PEST分析
  • 技術的進步
  • 法規方案
  • 合併和收購

第4章 市場分析:各檢驗類型

  • 簡介
  • 披衣菌感染
  • 淋病
  • 梅毒
  • HIV
  • HPV + 子宮頸癌症篩檢
  • HSV
  • 軟性下疳

第5章 市場分析:各地區

  • 簡介
  • 北美
  • 南美
  • 歐洲
  • 亞太地區
  • 中東
  • 非洲

第6章 競爭情形

  • 企業簡介
    • Vela Diagnostics USA Inc.
    • Roche Holdings AG
    • Alere, Inc.
    • Becton Dickinson & Company
    • bioMerieux
    • Danaher Corporation (Beckman Coulter)
    • Hologic, Inc.
    • binx health
    • Chembio Diagnostics
    • Pinpoint Science Inc.
    • bioLytical Laboratories

第7章

目錄

Title:
Diagnostic Testing of STDs Market, By Test Type (Chlamydia, Gonorrhea, Syphilis, HIV, HPV+pap smear, HSV, Chancroid), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027.

Diagnostic Testing of STDs are used for identification and diagnosis of sexually transmitted diseases. These diseases are transmitted through person-to-person sexual contact. Approval and launch of new diagnostic tests is expected to propel growth of the global diagnostic testing of STDs market over the forecast period. Moreover, increasing incidence of STDs in developing and developed economies along with increasing awareness is also expected to drive the market growth during the forecast period.

Key features of the study:

  • This report provides in-depth analysis of the Global Diagnostic Testing of STDs market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2020-2027), considering 2019 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the Global Diagnostic Testing of STDs market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include, Vela Diagnostics USA Inc., Roche Holdings AG, Alere, Inc., Becton Dickinson & Company, bioMerieux, Danaher Corporation (Beckman Coulter), Hologic, Inc., binx health, Chembio Diagnostics, Pinpoint Science Inc., and bioLytical Laboratories.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The Global Diagnostic Testing of STDs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global Diagnostic Testing of STDs market

Detailed Segmentation:

  • Global Diagnostic Testing of STDs Market, By Test Type:
    • Chlamydia
    • Gonorrhea
    • Syphilis
    • HIV
    • HPV+pap smear
    • HSV
    • Chancroid
  • Global Diagnostic Testing of STDs Market, By Region:
    • North America
      • By Test Type:
      • Chlamydia
      • Gonorrhea
      • Syphilis
      • HIV
      • HPV+pap smear
      • HSV
      • Chancroid
      • By Country
      • U.S.
      • Canada
    • Latin America
      • By Test Type:
      • Chlamydia
      • Gonorrhea
      • Syphilis
      • HIV
      • HPV+pap smear
      • HSV
      • Chancroid
      • By Country
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • By Test Type:
      • Chlamydia
      • Gonorrhea
      • Syphilis
      • HIV
      • HPV+pap smear
      • HSV
      • Chancroid
      • By Country
      • U.K.
      • Germany
      • France
      • Spain
      • Italy
      • Russia
      • Rest of Europe
    • Asia Pacific
      • By Test Type:
      • Chlamydia
      • Gonorrhea
      • Syphilis
      • HIV
      • HPV+pap smear
      • HSV
      • Chancroid
      • By Country
      • China
      • Japan
      • India
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • By Test Type:
      • Chlamydia
      • Gonorrhea
      • Syphilis
      • HIV
      • HPV+pap smear
      • HSV
      • Chancroid
      • By Country
      • GCC Countries
      • Israel
      • Rest of Middle East
    • Africa
      • By Test Type:
      • Chlamydia
      • Gonorrhea
      • Syphilis
      • HIV
      • HPV+pap smear
      • HSV
      • Chancroid
      • By Country
      • North Africa
      • Central Africa
      • South Africa
  • Company Profiles
    • Vela Diagnostics USA Inc. *
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Roche Holdings AG
    • Alere, Inc.
    • Becton Dickinson & Company
    • bioMerieux
    • Danaher Corporation (Beckman Coulter)
    • Hologic, Inc.
    • binx health
    • Chembio Diagnostics
    • Pinpoint Science Inc.
    • bioLytical Laboratories

"*" marked represents similar segmentation in other categories in the respective section..

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Test Type
    • Market Snippet, By Country
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Key Highlights
  • Product launch
  • PEST Analysis
  • Technological Advancements
  • Regulatory Scenario
  • Mergers and Acquisitions

4. Global Diagnostic Testing of STDs Market, By Test Type, 2019 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Chlamydia
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Gonorrhea
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Syphilis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • HIV
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • HPV+pap smear
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • HSV
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Chancroid
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

5. Global Diagnostic Testing of STDs Market, By Region, 2019 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2026
  • North America
    • Market Size and Forecast, By Test Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • U.S.
    • Canada
  • Latin America
    • Market Size and Forecast, By Test Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Test Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Test Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • Market Size and Forecast, By Test Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Test Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • North Africa
    • Central Africa
    • South Africa

6. Competitive Landscape

  • Company Profiles
    • Vela Diagnostics USA Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Roche Holdings AG
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Alere, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Becton Dickinson & Company
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • bioMerieux
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Danaher Corporation (Beckman Coulter)
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Hologic, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • binx health
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Chembio Diagnostics
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Pinpoint Science Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • bioLytical Laboratories
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies

7. Section

  • References
  • Research Methodology
  • About us and Sales Contact